CDNA
Caredx Inc

3,252
Mkt Cap
$883.61M
Volume
797,319.00
52W High
$26.37
52W Low
$10.96
PE Ratio
14.41
CDNA Fundamentals
Price
$18.50
Prev Close
$15.76
Open
$15.79
50D MA
$15.08
Beta
1.49
Avg. Volume
1.02M
EPS (Annual)
$0.9281
P/B
2.84
Rev/Employee
$513,515.39
Loading...
Loading...
News
all
press releases
CareDx (NASDAQ:CDNA) Raised to Hold at Zacks Research
Zacks Research upgraded shares of CareDx from a "strong sell" rating to a "hold" rating in a research report on Tuesday...
MarketBeat·1d ago
News Placeholder
More News
News Placeholder
SG Capital Management LLC Takes Position in CareDx, Inc. $CDNA
SG Capital Management LLC bought a new stake in shares of CareDx, Inc. (NASDAQ:CDNA - Free Report) during the second quarter, according to the company in its most recent 13F filing with the...
MarketBeat·6d ago
News Placeholder
Acadian Asset Management LLC Sells 243,776 Shares of CareDx, Inc. $CDNA
Acadian Asset Management LLC reduced its position in CareDx, Inc. (NASDAQ:CDNA - Free Report) by 67.8% during the second quarter, according to the company in its most recent filing with the...
MarketBeat·6d ago
News Placeholder
CareDx to Participate in Upcoming Investor Conferences
CareDx, Inc. (Nasdaq: CDNA)- The Transplant Company a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value...
Business Wire·12d ago
News Placeholder
Y Intercept Hong Kong Ltd Buys Shares of 19,474 CareDx, Inc. $CDNA
Y Intercept Hong Kong Ltd purchased a new position in CareDx, Inc. (NASDAQ:CDNA - Free Report) during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange...
MarketBeat·13d ago
News Placeholder
CareDx (NASDAQ:CDNA) Stock Rating Upgraded by Wall Street Zen
Wall Street Zen upgraded shares of CareDx from a "sell" rating to a "buy" rating in a research note on Saturday...
MarketBeat·14d ago
News Placeholder
CareDx Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
CareDx, Inc. (Nasdaq: CDNA) The Transplant Company a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value...
Business Wire·15d ago
News Placeholder
CareDx (NASDAQ:CDNA) Given New $25.00 Price Target at BTIG Research
BTIG Research raised their price objective on CareDx from $22.00 to $25.00 and gave the stock a "buy" rating in a research note on Thursday...
MarketBeat·15d ago
News Placeholder
CareDx (NASDAQ:CDNA) Shares Gap Up - Here's Why
CareDx (NASDAQ:CDNA) Shares Gap Up - Here's Why...
MarketBeat·16d ago
News Placeholder
CareDx Announces New Precision Kidney Transplant Data and Product Innovations at ASN Kidney Week 2025
CareDx, Inc. (Nasdaq: CDNA) The Transplant Company a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value...
Business Wire·16d ago

Latest CDNA News

View

Advertisement|Remove ads.

Advertisement|Remove ads.